DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Otros (Other)
Vaccination strategies in structured populations under partial immunity and reinfection
Optimal protocols of vaccine administration to minimize the effects of infectiousdiseases depend on a number of variables that admit different degrees of control.Examples include the characteristics of the disease and how it impacts on differentgroups of individuals as a function of sex, age or socioeconomic status, its transmissionmode, or the demographic structure of the affected population. Here we introduce acompartmental model of infection propagation with vaccination and reinfection andanalyse the effect that variations on the rates of these two processes have on theprogression of the disease and on the number of fatalities. The population is split intotwo groups to highlight the overall effects on disease caused by different relationshipsbetween vaccine administration and various demographic structures. As a practicalexample, we study COVID-19 dynamics in various countries using real demographicdata. The model can be easily applied to any other disease and demographic structurethrough a suitable estimation of parameter values. Two main conclusions stand out.First, the higher the fraction of reinfected individuals, the higher the likelihood that thedisease becomes quasi-endemic. Second, optimal vaccine roll-out depends ondemographic structure and disease fatality, so there is no unique vaccination protocol,valid for all countries, that minimizes the effects of a specific disease. Simulations of thegeneral model can be carried out at this interactive webpage, The authors are indebted to A. Vespignani for support with the use of their data. 461
Grants PID2020-113284GB-C21 (I.A., S.M.) and BADS (PID2019-109320GB-100, S.A.) 462
funded by MCIN/AEI/10.13039/501100011033. The Spanish MICINN has also funded 463
the “Severo Ochoa” Centers of Excellence to CNB, SEV 2017-0712, and the special 464
grant PIE 2020-20E079 (CNB) entitled “Development of protection strategies against 465
SARS-CoV-2”., No